GSK -4178116 (GSK4178116A) is under development for the prevention of varicella (chickenpox) caused by the new strain (US) of varicella-zoster virus (VZV). It is administered through subcutaneous ...

MRNACR-04 is under clinical development by GSK and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.

At close: January 3 at 11:40:19 AM EST ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Beauty was extremely important in ancient Greece and not just for women but for men, as well. As admirers of beauty, ancient Greeks placed great emphasis on healthy skin, and, naturally, they ...